INS and gestational diabetes: The low-risk group identified by the simple tool had a lower risk of requiring insulin treatment (OR 0.23 95% CI 0.13–0.40), although no difference in the risk of GDM-related composite adverse birth outcomes was noted (OR 0.71, 95% CI 0.44–1.16) (Table S5).